Source:http://linkedlifedata.com/resource/umls/label/A17288787
| Subject | Predicate | Object | Context |
|---|---|---|---|
| umls-label:A17288787 | rdf:type | skos-xl:Label | lld:umls |
| umls-label:A17288787 | skos:notation | 288533 | lld:umls |
| umls-label:A17288787 | skos:note | FDA National Drug Code Directory | lld:umls |
| umls-label:A17288787 | skos-xl:literalForm | HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN 40 MCG / HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN 40 MCG / HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN 20 MCG / HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN 20 MCG INTRAMUSCULAR INJECTION, SUSPENSION [GARDASIL] | lld:umls |
| umls-concept:C1725928 | skos-xl:altLabel | umls-label:A17288787 | lld:umls |